X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare AJANTA PHARMA with Abbott India - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

AJANTA PHARMA vs ABBOTT INDIA - Comparison Results

ABBOTT INDIA 
   Change

Formerly known as Knoll Pharmaceuticals Limited, Abbott India Limited (AIL) is a subsidiary of Abbott Capital India Limited in which the latter holds about 69% stake. It is involved in the discovery, development, manufacture and marketing of pharmace... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    AJANTA PHARMA ABBOTT INDIA AJANTA PHARMA/
ABBOTT INDIA
 
P/E (TTM) x 19.5 40.6 48.1% View Chart
P/BV x 4.5 11.7 38.2% View Chart
Dividend Yield % 0.0 0.5 -  

Financials

 AJANTA PHARMA   ABBOTT INDIA
EQUITY SHARE DATA
    AJANTA PHARMA
Mar-18
ABBOTT INDIA
Mar-17
AJANTA PHARMA/
ABBOTT INDIA
5-Yr Chart
Click to enlarge
High Rs1,8185,190 35.0%   
Low Rs1,1064,351 25.4%   
Sales per share (Unadj.) Rs239.51,382.9 17.3%  
Earnings per share (Unadj.) Rs52.8130.2 40.6%  
Cash flow per share (Unadj.) Rs59.5137.9 43.1%  
Dividends per share (Unadj.) Rs040.00 0.0%  
Dividend yield (eoy) %00.8 0.0%  
Book value per share (Unadj.) Rs230.0652.7 35.2%  
Shares outstanding (eoy) m88.7721.25 417.7%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x6.13.4 177.0%   
Avg P/E ratio x27.736.6 75.6%  
P/CF ratio (eoy) x24.634.6 71.0%  
Price / Book Value ratio x6.47.3 87.0%  
Dividend payout %030.7 0.0%   
Avg Mkt Cap Rs m129,782101,373 128.0%   
No. of employees `0006.83.1 220.4%   
Total wages/salary Rs m3,7653,453 109.0%   
Avg. sales/employee Rs Th3,128.49,531.9 32.8%   
Avg. wages/employee Rs Th554.01,119.9 49.5%   
Avg. net profit/employee Rs Th689.7897.3 76.9%   
INCOME DATA
Net Sales Rs m21,25829,387 72.3%  
Other income Rs m242576 41.9%   
Total revenues Rs m21,49929,963 71.8%   
Gross profit Rs m6,5843,973 165.7%  
Depreciation Rs m596164 362.7%   
Interest Rs m420 20.1%   
Profit before tax Rs m6,2264,365 142.6%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,5391,598 96.3%   
Profit after tax Rs m4,6862,767 169.4%  
Gross profit margin %31.013.5 229.1%  
Effective tax rate %24.736.6 67.5%   
Net profit margin %22.09.4 234.2%  
BALANCE SHEET DATA
Current assets Rs m12,23618,906 64.7%   
Current liabilities Rs m3,4616,297 55.0%   
Net working cap to sales %41.342.9 96.2%  
Current ratio x3.53.0 117.8%  
Inventory Days Days6062 96.8%  
Debtors Days Days8422 390.4%  
Net fixed assets Rs m11,1401,159 961.4%   
Share capital Rs m177213 83.2%   
"Free" reserves Rs m20,23713,657 148.2%   
Net worth Rs m20,41413,869 147.2%   
Long term debt Rs m100-   
Total assets Rs m24,48620,638 118.6%  
Interest coverage x1,519.4215.0 706.8%   
Debt to equity ratio x00-  
Sales to assets ratio x0.91.4 61.0%   
Return on assets %19.213.5 141.9%  
Return on equity %23.019.9 115.1%  
Return on capital %30.531.6 96.5%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m11,6670-   
Fx outflow Rs m1,6160-   
Net fx Rs m10,0520-   
CASH FLOW
From Operations Rs m2,8543,072 92.9%  
From Investments Rs m-2,604-1,554 167.6%  
From Financial Activity Rs m-2-898 0.2%  
Net Cashflow Rs m248621 40.0%  

Share Holding

Indian Promoters % 73.8 0.0 -  
Foreign collaborators % 0.0 75.0 -  
Indian inst/Mut Fund % 1.6 7.9 19.6%  
FIIs % 7.6 0.1 7,600.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 17.0 17.1 99.4%  
Shareholders   20,968 18,270 114.8%  
Pledged promoter(s) holding % 4.4 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare AJANTA PHARMA With:   PLETHICO PHARMA  BIOCON LTD  FULFORD INDIA  NATCO PHARMA  DIVIS LABORATORIES  

Compare AJANTA PHARMA With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 219 Points Lower; Energy and Auto Stocks Witness Selling(Closing)

After witnessing volatile trades during the day, Indian share markets ended their session on a negative note. Losses were largely seen in the oil & gas sector, auto sector.

Related Views on News

ABBOTT INDIA at All Time High; BSE HEALTHCARE Index Up 0.5%

Jun 25, 2018 | Updated on Jun 25, 2018

ABBOTT INDIA share price has hit an all time high at Rs 7,550 (up 1.60%). The BSE HEALTHCARE Index is up by 0.49%. Among the top gainers in the BSE HEALTHCARE Index today are ABBOTT INDIA (up 1.60%) and SANOFI INDIA (up 0.37%). The top losers include GSK PHARMA (down 0.04%) and JUBILANT LIFE SCIENCES (down 0.13%).

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

More Views on News

Most Popular

Alert: Pharma Stocks Are About to Shoot Up - And a Superb Stock for Trading(Profit Hunter)

Jun 13, 2018

The ailing pharma stocks are bouncing back to health. Read this to find out the best way to profit from them.

Will You Dump Your Client if You're Busy? Inox Wind's Auditor Just Did...(The 5 Minute Wrapup)

Jun 14, 2018

After Inox Wind, you may see more auditors resigning And the reasons can be as funny as they can get.

GST Will Not Solve Problem of High Prices of Petrol and Diesel(Vivek Kaul's Diary)

Jun 13, 2018

Though it will bring transparency in their pricing and that in itself will be a welcome move.

Should You Invest In Mirae Asset Healthcare Fund?(Outside View)

Jun 15, 2018

Mirae Asset Mutual Fund launches NFO - Mirae Asset Helathcare Fund.

This Behaviour is Injurious to Wealth Building(Sector Info)

Jun 13, 2018

Blindly following the herd can be the biggest wealth destroyer.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

AJANTA PHARMA SHARE PRICE


Jun 25, 2018 (Close)

TRACK AJANTA PHARMA

  • Track your investment in AJANTA PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

AJANTA PHARMA 5-YR ANALYSIS

COMPARE AJANTA PHARMA WITH

MARKET STATS